Convergent and divergent immune aberrations in COVID-19, post-COVID-19-interstitial lung disease, and idiopathic pulmonary fibrosis
Bochra Tourki(University of South Florida), Jose D. Herazo‐Maya(University of South Florida), Dylan Allen(University of South Florida), Αrgyris Τzouvelekis(University of Patras), Maria G. Kapetanaki(University of Florida), M.R. Qureshi(University of South Florida), Kami Kim(University of South Florida), Panayiotis V. Benos(University of Florida), K. Patel(University of South Florida), Brenda Juan-Guardela(Yale University), Carole Y. Perrot(University of South Florida), Iset M Vera(University of South Florida), Ricardo Restrepo‐Jaramillo(University of South Florida), Forouzandeh Farsaei(University of South Florida), David Rutenberg(University of South Florida), Debabrata Bandyopadhyay(University of South Florida), Zainab Fatima(West Virginia University), Minxue Jia(University of Pittsburgh), Alyssa Arsenault(University of South Florida), Τheodoros Karampitsakos(University of South Florida)
Cited by 9
Related Papers
Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3
|Proceedings of the National Academy of Sciences|2013|644
PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis
|Journal of Clinical Investigation|2014|613
PD-1 up-regulation on CD4 <sup>+</sup> T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production
|Science Translational Medicine|2018|364
Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function
|Nature Medicine|2017|361
Peripheral Blood Mononuclear Cell Gene Expression Profiles Predict Poor Outcome in Idiopathic Pulmonary Fibrosis
|Science Translational Medicine|2013|350